astemizole has been researched along with nedocromil in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bonini, S; Brovarone, FV; Miglior, M; Negrini, A; Pezzi, PP; Ruggieri, ML; Scullica, L; Secchi, AG; Vargiu, G | 1 |
Biondi, RM; Blumenthal, MM; Bukstein, DA; Dockhorn, RJ; Filley, WV; Fink, J; Goldstein, S; Graft, DF; Hirsch, SR; Joos, TH; Melamed, J; Rowe, MS; Townley, RG | 1 |
2 trial(s) available for astemizole and nedocromil
Article | Year |
---|---|
Nedocromil sodium and astemizole, alone or combined, in the treatment of seasonal allergic conjunctivitis. A multicentre double blind clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Astemizole; Child; Conjunctivitis, Allergic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nedocromil; Quinolones | 1993 |
Tilarin in combination with astemizole.
Topics: Administration, Intranasal; Adolescent; Adult; Anti-Allergic Agents; Astemizole; Child; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nedocromil; Rhinitis, Allergic, Seasonal; Severity of Illness Index | 1996 |
2 other study(ies) available for astemizole and nedocromil
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |